Proliferation marker (ki67) in sub-categorization of neuroendocrine tumours of the lung | Zendy

Rashi Garg | Zendy; Amanjit Bal | Zendy; Ashim Das | Zendy; Navneet Singh | Zendy; Harkant Singh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proliferation marker (ki67) in sub-categorization of neuroendocrine tumours of the lung

Author(s) -

Rashi Garg,

Amanjit Bal,

Ashim Das,

Navneet Singh,

Harkant Singh

Publication year - 2018

Publication title -

turkish journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.305

H-Index - 14

eISSN - 1309-5730

pISSN - 1018-5615

DOI - 10.5146/tjpath.2018.01436

Subject(s) - neuroendocrine tumors , small cell lung carcinoma , pathology , neuroendocrine differentiation , carcinoid tumors , lymphovascular invasion , carcinoma , small cell carcinoma , medicine , lung , carcinoid tumour , immunohistochemistry , ki 67 , proliferation index , cancer , metastasis , prostate cancer

The 2015 WHO classification classifies neuroendocrine tumours (NET) of the lung into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma and small cell carcinoma based on morphology alone. Mitosis is the major parameter for this classification, and thus several studies have focused on the role of Ki67 in these tumours but without conclusive results. The aim of the study was to categorize neuroendocrine tumours of the lung based on morphology and to assess the utility of Ki67 in diagnosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research